Pioglitazone: No Longer a Worry for Bladder Cancer?
作者信息
Chedgy Edmund C P, Black Peter C
机构信息
Vancouver Prostate Centre University of British Columbia Vancouver, BC, Canada.
出版信息
Urology. 2016 May;91:19-20. doi: 10.1016/j.urology.2016.01.015. Epub 2016 Feb 15.
Abstract
摘要
相似文献
1
Pioglitazone: No Longer a Worry for Bladder Cancer?
Urology. 2016 May;91:19-20. doi: 10.1016/j.urology.2016.01.015. Epub 2016 Feb 15.
2
Association between pioglitazone and urothelial bladder cancer.
Urology. 2012 Jul;80(1):1-4. doi: 10.1016/j.urology.2012.03.032. Epub 2012 May 23.
3
Possible link of pioglitazone with bladder cancer in Japanese patients with type 2 diabetes.
Diabetes Res Clin Pract. 2013 Feb;99(2):e21-3. doi: 10.1016/j.diabres.2012.11.013. Epub 2012 Dec 7.
4
Updated Review Confirms Potential Risk of Bladder Cancer with Pioglitazone.
Am J Nurs. 2017 Apr;117(4):25. doi: 10.1097/01.NAJ.0000515230.35655.54.
5
Pioglitazone and the risk of bladder cancer.
BMJ. 2012 May 30;344:e3500. doi: 10.1136/bmj.e3500.
6
[Pioglitazone and the risk of bladder cancer].
Nihon Rinsho. 2016 Apr;74 Suppl 2:442-6.
7
Meta-analysis confirms raised risk of bladder cancer from pioglitazone.
BMJ. 2012 Jul 4;345:e4541. doi: 10.1136/bmj.e4541.
8
Eight cases of bladder cancer in pioglitazone users from India.
J Assoc Physicians India. 2012 Dec;60:66.
9
Pioglitazone and bladder cancer: the pros and cons.
J Assoc Physicians India. 2012 Jan;60:72-3.
10
Pioglitazone Use and Risk of Bladder Cancer.
JAMA. 2015 Dec 15;314(23):2568. doi: 10.1001/jama.2015.13909.
引用本文的文献
1
Pioglitazone Use and Risk of Bladder Cancer: an Study.
Int J Med Sci. 2018 Jan 8;15(3):228-237. doi: 10.7150/ijms.22408. eCollection 2018.
2
Nonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment Options.
Clin Med Insights Ther. 2016;8:75-84. doi: 10.4137/cmt.s18885. Epub 2016 Dec 18.
Zotero 插件